Back

The impact of the development of TAVI on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.

27 August 2016 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Aortic valve disease Aortic valve disease ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Claire Bouleti

La Miletrie University Hospital Centre, Poitiers (France)

28 More presentations in this session

Presentation thumbnail
Doctor G. Witberg (Petah Tikva, IL)
Presentation thumbnail
Doctor V. Mauri (Cologne, DE)
Abstract
Presentation thumbnail
Doctor B. Wernly (Salzburg, AT)
Abstract Slides
Presentation thumbnail
Professor C. Muneretto (Brescia, IT)
Abstract Slides
Presentation thumbnail
Doctor S. Nishimura (Tenri, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Aortic valve disease

The Event

Event poster

ESC Congress 2016

27 August 2016 11:00 CET
You may be interested in
thumbnail
Webinar
Aortic stenosis treatment options - which therapy for which patient?
21 December 2021
thumbnail
Congress Presentation
Long-term outcomes of TAVI in patients with cancer: insights into early and late mortality trends
21 June 2025
thumbnail
Congress Session
20 years of TAVI: the remaining unmet needs
23 June 2023
thumbnail
Congress Presentation
Urgent transcatheter aortic valve implantation in patients with severe aortic stenosis and acute heart failure
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources